Brimonidine gel for the treatment of persistent heliotrope rash in a patient with amyopathic dermatomyositis: a case report
暂无分享,去创建一个
[1] V. Werth,et al. Improvement in the cutaneous disease activity of patients with dermatomyositis is associated with a better quality of life , 2015, The British journal of dermatology.
[2] R. Pomerantz,et al. Brimonidine effective but may lead to significant rebound erythema. , 2014, Journal of the American Academy of Dermatology.
[3] J. Levitt,et al. Rebound erythema and burning sensation from a new topical brimonidine tartrate gel 0.33%. , 2014, Journal of the American Academy of Dermatology.
[4] L. Punzi,et al. The clinical features, diagnosis and classification of dermatomyositis. , 2014, Journal of autoimmunity.
[5] V. Werth,et al. Quality of life in dermatomyositis. , 2011, Journal of the American Academy of Dermatology.
[6] J. Ko,et al. Successful Treatment of Cutaneous Lesions of Dermatomyositis with Topical Pimecrolimus , 2011, Annals of dermatology.
[7] S. Feldman,et al. Cutaneous symptoms of dermatomyositis significantly impact patients' quality of life. , 2006, Journal of the American Academy of Dermatology.
[8] F. Walker,et al. Dermatomyositis: a dermatology-based case series. , 1998, Journal of the American Academy of Dermatology.